Semaglutide 2mg Dosage & Reconstitution Guide

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the effects of the naturally occurring hormone GLP-1. Originally developed for type 2 diabetes research, it has become one of the most studied peptides for metabolic and weight management research.

The peptide works by binding to GLP-1 receptors found in the pancreas, brain, and gastrointestinal tract. Research has demonstrated effects on insulin secretion, glucagon suppression, gastric emptying, and appetite signaling pathways.

Semaglutide has a significantly extended half-life compared to native GLP-1 (approximately 7 days vs. minutes), allowing for once-weekly administration in research protocols. This is achieved through fatty acid acylation that enables albumin binding.

Quick Reference

Reconstitution Guide

Materials Needed

• Semaglutide 2mg lyophilized vial
• Bacteriostatic water (BAC water)
• Insulin syringes (U-100, 29-31 gauge)
• Alcohol swabs
• Sharps container

Step-by-Step Instructions

1. Prepare your workspace — Clean your work area and gather all materials. Wash hands thoroughly.

2. Clean the vial stoppers — Wipe the Semaglutide vial stopper and BAC water vial with alcohol swabs. Allow to dry completely.

3. Draw the BAC water — Using a sterile syringe, draw 1mL of bacteriostatic water.

4. Add water to peptide vial — Insert the needle into the Semaglutide vial and slowly inject the BAC water down the inside wall of the vial. Do not spray directly onto the powder.

5. Allow to dissolve — Semaglutide may take 5-10 minutes to fully dissolve. Gently swirl occasionally — never shake vigorously.

6. Verify dissolution — The solution should be completely clear and colorless. If cloudy or particles remain, continue gentle swirling.

7. Label and store — Write the reconstitution date on the vial. Store in refrigerator immediately.

Dosage Protocol

Concentration Calculations

With 2mg peptide in 1mL BAC water:

• Resulting Concentration: 2.00mg/mL = 2000mcg/mL
• Per unit (U-100 syringe): 20.0mcg per unit

Common Dose Calculations

Injection Guide

Subcutaneous Administration

1. Clean the injection site with an alcohol swab
2. Pinch a fold of skin (abdomen, thigh, or upper arm)
3. Insert needle at 90° angle
4. Inject slowly and steadily
5. Wait 5-10 seconds before withdrawing needle
6. Apply light pressure if needed — do not rub

Site Rotation

Rotate between these areas:

• Abdomen (2+ inches from navel) — most common
• Outer thigh (front/outer area)
• Back of upper arm

Storage Requirements

Lyophilized (Powder Form)

Reconstituted (Mixed with BAC Water)

Research Considerations

Mechanism of Action

GLP-1 receptor agonism: glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, CNS appetite regulation, observed cardioprotective effects

Key Research Findings

Clinical trials (STEP program, SUSTAIN program) demonstrated significant effects on body weight, improvements in glycemic parameters, and cardiovascular outcome benefits in at-risk populations.

Safety & Handling

• Use sterile technique for all preparations
• Never reuse needles or syringes
• Dispose of sharps properly in designated containers
• Store away from children and unauthorized persons
• Semaglutide is for research purposes only

Sourcing for Research

Source from verified suppliers that provide third-party testing and certificates of analysis (COA) for each batch. Compare purity documentation, shipping conditions, and batch traceability before purchasing research materials.

Scientific References

1. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — NEJM
2. Semaglutide and Cardiovascular Outcomes (SUSTAIN-6) — Lancet

Last updated: February 2026

This information is for educational and research purposes only. Semaglutide is a research peptide not intended for human consumption. Always follow applicable laws and institutional guidelines.